Both retail giants now have clinical trial businesses as Walgreens announces its entrance into the clinical trial space. But CVS can use Aetna to tap millions of additional patients.
Layoffs intensify for digital health: Headcount has become the release valve for a health tech sector that, until recently, enjoyed unprecedented growth and funding. Continued layoffs could slow innovation.
Remote surgery platform Proximie raised $80M. We unpack how it solves typical telehealth connectivity barriers and why more US health systems are becoming interested in the tech.
We explore key findings from a new survey on healthcare affordability and consider how providers can ease patients’ financial burdens.
Doctor search and booking company Sesame Health raised $27M as patients lose loyalty to physicians—especially if they have lousy ratings online.
Consumer tech powers wider-scale paranoia research: A study uses ordinary tech devices to research paranoia to expand understanding of the condition beyond traditional methods.
We unpack data from a new Walmart-powered healthcare provider survey and detail how the findings fit into Walmart’s broader rural healthcare strategy.
We explore how Happify’s plan to launch its digital therapy in European markets could help its case among pharma companies in the US.
Digital opioid treatments are sticky: Boulder Care nabs $36M and boasts its industry-leading retention rates. We detail how telehealth support and a steady, multipronged approach help patients stick to their SUD treatment regimens.
Digital health ed goes global: A digital health hub aims to upskill healthcare workers and drive health tech innovation worldwide. It could help connect isolated rural providers with academic hospitals’ expertise.
Olympus develops virtual collaboration platform for digital health: Leveraging video, AI, and collaboration tech can bring remote experts into procedure rooms and facilitate remote medical training for more successful treatments.
Teladoc got slapped with a lawsuit alleging it misled investors about its 2022 financial expectations. Fewer COVID-19 concerns and increasing competition could be driving losses.